David Reinhart

Benchmarking of commercially available CHO cell culture media for antibody production

David Reinhart, Lukas Damjanovic, Christian Kaisermayer et al. · Applied Microbiology and Biotechnology · 2015 · 142 citations · Full text

Life Sciences, Biotechnology, Cell Biology +17

Cloning of the major histocompatibility complex class II promoter binding protein affected in a hereditary defect in class II gene regulation.

Walter Reith, Emmanuèle Barras, Sarah W. Satola et al. · Proceedings of the National Academy of Sciences · 1989 · 141 citations · Full text

Life Sciences, Genetics, Molecular Biology +17

Bioprocessing of Recombinant CHO-K1, CHO-DG44, and CHO-S: CHO Expression Hosts Favor Either mAb Production or Biomass Synthesis

David Reinhart, Lukas Damjanovic, Christian Kaisermayer et al. · Biotechnology Journal · 2018 · 89 citations · Full text

Life Sciences, Biotechnology, Genetics +17

Using lean methodology to improve productivity in a hospital oncology pharmacy

Peter M. Sullivan, Scott A. Soefje, David Reinhart et al. · American Journal of Health-System Pharmacy · 2014 · 56 citations

Pharmacy, Hospital Pharmacy, Oncology Pharmacy +17

Proteomic differences in recombinant CHO cells producing two similar antibody fragments

Wolfgang Sommeregger, Patrick Mayrhofer, Willibald Steinfellner et al. · Biotechnology and Bioengineering · 2016 · 39 citations · Full text

Life Sciences, Biotechnology, Cell Biology +17